MENU
IONS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ionis Pharmaceuticals (IONS) Ownership - Who owns Ionis Pharmaceuticals?
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.8B
P/E Ratio
N/A
Total Cash
2.3B
Projected Growth
N/A
Total Debt
1.42B
Revenue
705.14M
Risk (Beta)
-0.04
Dividend Yield
N/A
Total Cash/Share
14.45
Total Debt/Equity
N/A
Revenue/Share
4.72 USD as % of share price
Fundamentals
IONS
Capitalization
4.8B
P/E Ratio
N/A
Risk (Beta)
-0.04
Dividend Yield
N/A
Total Cash
2.3B
Total Cash/Share
14.45
Total Debt
1.42B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.72%
Revenue
705M
ROE
N/A
Book Value
588M
P/B Ratio
7.36
Cash Flow
N/A
Earnings
-3.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
158K
Current Ratio
8.47
Current Revenue Per Employee
244418.55
Dividends Per Share - Security
N/A
EBITDA
-353.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.31
Revenue To Assets
-15.15
Shares Held By Institutions
14.4B
Shares Outstanding - Current
159M
Total Liabilities
2.42B
Total Volume MTD
N/A
Value
-1
Gain YTD
-22.025
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of antisense drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com